Is doximity publicly traded?

Can I buy Doximity stock?

Buy Doximity shares from these brokerages Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN. Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Did Doximity go public?

Doximity has released two earnings results since going public. The first one was for the first quarter of fiscal 2022 (period ending June 30, 2021), where it reported sales of $72.7 million which doubled the prior-year period’s total.

What company owns Doximity?

Doximity co-founder and CEO Jeff Tangney owns a $2.9 billion stake in the company after its New York Stock Exchange debut this week. Tangney started the company in 2010 and, prior to the IPO, hadn’t raised outside capital since 2014.

How many shares of Doximity are there?

Doximity has 277.33 million shares outstanding. The number of shares has increased by 142.23% in one year.

Is DOCS a good stock to buy?

Out of 13 analysts, 4 (30.77%) are recommending DOCS as a Strong Buy, 5 (38.46%) are recommending DOCS as a Buy, 3 (23.08%) are recommending DOCS as a Hold, 0 (0%) are recommending DOCS as a Sell, and 1 (7.69%) are recommending DOCS as a Strong Sell.

Should I sell my doximity stock?

10 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Doximity in the last twelve months. There are currently 1 sell rating, 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Doximity stock.

What date did doximity go public?

June 24, 2021
When Did Doximity Go Public? Doximity’s shares were listed on the New York Stock Exchange or NYSE on June 24, 2021. Doximity’s journey to becoming a publicly-listed company started in 2010 when the company was first established.

Should I buy Doximity stock?

The consensus among Wall Street equities research analysts is that investors should “buy” Doximity stock.

Is Doximity a profitable company?

Doximity brought in revenue of $116 million in 2019 and revenue grew 78% to reach $207 million in 2020. The company is profitable, bringing in $30 million and $50 million in net income in 2019 and 2020, respectively.

Should I buy doximity stock?

The consensus among Wall Street equities research analysts is that investors should “buy” Doximity stock.

Is doximity overvalued?

Is Doximity overvalued? According to Wall Street analysts Doximity’s price is currently Undervalued.

Is doximity undervalued?

The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.111 by $0.179. According to Wall Street analysts Doximity’s price is currently Undervalued.

Is doximity a buy or sell?

10 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Doximity in the last year. There are currently 1 sell rating, 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Doximity stock.

Should I invest in DOCS?

The financial health and growth prospects of DOCS, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.

Should you buy doximity stock?

Over on Wall Street, Doximity has a Moderate Buy consensus rating. Four analysts have Buy ratings, joining three Hold ratings. Notably, one hold rating comes with a $40 price target, or more than 35% lower than the current price. The average Doximity price target of $62.86 implies 14.8% downside from the current price.

Is DOCS a buy or sell?

Out of 13 analysts, 4 (30.77%) are recommending DOCS as a Strong Buy, 5 (38.46%) are recommending DOCS as a Buy, 3 (23.08%) are recommending DOCS as a Hold, 0 (0%) are recommending DOCS as a Sell, and 1 (7.69%) are recommending DOCS as a Strong Sell. What is DOCS’s earnings growth forecast for 2022-2024?

Is Doximity good stock?

Doximity is a great company with a strong outlook and a dominant position in its niche industry. It has real change-making potential and a healthy moat, all signs of a great growth stock.

Is Doximity good investment?

Doximity is also highly profitable, generating $14.1 million, $22 million, and $78.4 million in free cash flow during each of the last three years, respectively. With gross margin close to 90% and an asset-light model, Doximity’s business is set up to have incredibly high profit margins.

Why is doximity dropping?

Investing.com — Medical social networking site Doximity Inc (NYSE:DOCS) is down 7% after going public on Thursday. Shares more than doubled in its debut after raising about $500 million.

Why is doximity down today?

Doximity issued a glowing quarterly earnings report after the market closed on Tuesday, but investors looked past the results. The stock is falling today in response to the impending expiration of a lock-up agreement currently keeping inside investors from selling their shares.